Privia Health Group, Inc. 是一家位於美國的人口健康技術及醫療實踐管理公司。
財務指標
營業收入
2026-06-30
$632.63M
2026-03-31
$603.84M
2025-12-31
$541.17M
2025-09-30
$580.41M
營業支出
2026-06-30
$620.85M
2026-03-31
$49.6M
2025-12-31
$38.37M
2025-09-30
$46.6M
淨利潤
2026-06-30
$9.04M
2026-03-31
$3.06M
2025-12-31
$9.15M
2025-09-30
$6.86M
淨利潤率
2026-06-30
1.43%
2026-03-31
0.5%
2025-12-31
1.69%
2025-09-30
1.18%
每股收益
2026-06-30
$0.07
2026-03-31
$0.19
2025-12-31
$0.07
2025-09-30
$0.29
息稅折舊攤銷前利潤
2026-06-30
$20.1M
2026-03-31
$12.59M
2025-12-31
$16.02M
2025-09-30
$19.44M
有效稅率
2026-06-30
41.89%
2026-03-31
60.15%
2025-12-31
20.83%
2025-09-30
41.18%
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$632.63M
$603.84M
$541.17M
$580.41M
營業支出
$620.85M
$49.6M
$38.37M
$46.6M
淨利潤
$9.04M
$3.06M
$9.15M
$6.86M
淨利潤率
1.43%
0.5%
1.69%
1.18%
每股收益
$0.07
$0.19
$0.07
$0.29
息稅折舊攤銷前利潤
$20.1M
$12.59M
$16.02M
$19.44M
有效稅率
41.89%
60.15%
20.83%
41.18%
常見問題
PRVA represents the common stock of Privia Health Group, Inc., a healthcare technology company. The shares trade on the Nasdaq Global Select Market, allowing investors to participate in the company's performance. PRVA stock provides exposure to a business focused on physician enablement and value-based care. The stock's price, trading volume, and other real-time data are available on the PRVA quote page.
PRVA operates within the healthcare sector, specifically in healthcare technology and physician practice management. Its business model centers on providing a platform that supports independent physicians and practices with technology, administrative services, and population health management. The company also facilitates participation in value-based care arrangements, positioning it at the intersection of healthcare services and health information technology.
The latest PRVA stock performance, including daily price changes and recent trends, is displayed on the stock detail page. Since price movements are subject to market conditions, the most accurate and current performance data should be referenced directly from the live quote and charts provided. This ensures you see up-to-date information without relying on stale or hypothetical figures.
Valuation of PRVA can be assessed through metrics such as price-to-sales, price-to-earnings, and enterprise value-to-EBITDA, compared with peers in the healthcare technology and physician enablement space. Because these metrics fluctuate with stock price and financial results, the exact values are not fixed. Investors should review the latest financial statements and any valuation ratios shown on the PRVA page for current context.
PRVA shares may be eligible for pre-market and after-hours trading sessions, depending on your brokerage. These extended sessions typically have lower liquidity and wider spreads than regular market hours. Not all brokers offer this feature, and trading outside standard hours carries additional risks. Check with your broker and view the PRVA quote page for available session information.
Risks specific to PRVA include dependence on relationships with physician practices, regulatory changes in healthcare reimbursement, and competition from other healthcare technology platforms. Broader market risks, such as economic downturns and interest rate shifts, can also affect the stock. Additionally, as a growth-oriented company, PRVA may be sensitive to changes in investor sentiment and quarterly performance relative to expectations.